Population pharmacokinetics of amlodipine in hypertensive children and adolescents. 2006

Joseph T Flynn, and Milap C Nahata, and John D Mahan, and Ronald J Portman, and
Division of Pediatric Nephrology, Children's Hospital at Montefiore/Albert Einstein College of Medicine, Bronx, New York, USA.

A population pharmacokinetic study was conducted in 74 hypertensive children (mean age 10.4 +/- 4.4 years [mean +/- SD]) receiving amlodipine (mean dose 0.17 +/- 0.13 mg/kg/d) chronically. Multiple blood samples were obtained from each subject to characterize amlodipine pharmacokinetics. Plasma amlodipine concentrations were determined by liquid chromatography/mass spectrophotometry with multiple-reaction monitoring detection. Population pharmacokinetic analysis was performed using NONMEM. Amlodipine concentrations were similar in subjects dosed either once or twice daily. Amlodipine pharmacokinetics were well described by a 1-compartment model with first-order absorption and elimination. For a subject at the population median weight (45 kg), predicted apparent clearances (CL/F) were 23.7 L/h for males and 17.6 L/h for females, and the apparent volume of distribution (V/F) was 25.1 L/kg. Dosing frequency did not appear to affect amlodipine concentrations in children. Weight-adjusted CL/F and V/F of amlodipine in younger children were significantly greater than in older children, suggesting a need for higher doses when treating young children with amlodipine.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Joseph T Flynn, and Milap C Nahata, and John D Mahan, and Ronald J Portman, and
January 1988, Journal of cardiovascular pharmacology,
Joseph T Flynn, and Milap C Nahata, and John D Mahan, and Ronald J Portman, and
July 2001, Journal of clinical pharmacology,
Joseph T Flynn, and Milap C Nahata, and John D Mahan, and Ronald J Portman, and
August 2003, European journal of clinical pharmacology,
Joseph T Flynn, and Milap C Nahata, and John D Mahan, and Ronald J Portman, and
January 2003, American journal of therapeutics,
Joseph T Flynn, and Milap C Nahata, and John D Mahan, and Ronald J Portman, and
February 2024, British journal of clinical pharmacology,
Joseph T Flynn, and Milap C Nahata, and John D Mahan, and Ronald J Portman, and
November 2020, Clinical and translational science,
Joseph T Flynn, and Milap C Nahata, and John D Mahan, and Ronald J Portman, and
December 2019, Journal of clinical pharmacology,
Joseph T Flynn, and Milap C Nahata, and John D Mahan, and Ronald J Portman, and
October 2000, American journal of hypertension,
Joseph T Flynn, and Milap C Nahata, and John D Mahan, and Ronald J Portman, and
November 1997, International journal of clinical pharmacology and therapeutics,
Joseph T Flynn, and Milap C Nahata, and John D Mahan, and Ronald J Portman, and
April 2001, European journal of clinical pharmacology,
Copied contents to your clipboard!